November 12, 2020

12 Nov 20 | AU | Celltrion | The TGA approves Celltrion's subcutaneous "biobetter" infliximab product Remsima in auto-injection pen and PFS presentations. This is the first subcut infliximab product to be approved in Australia.

26 Oct 20 | All | Samsung Bioepis | S...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags